The India-Sweden Healthcare Innovation Centre, a collaboration between the Swedish Trade Commissioner’s Office, AIIMS New Delhi and AIIMS Jodhpur, launched a specialized training program for nurses to equip them with the world-class practical know-how required in managing diabetes. In the first training, 30 nurses from AIIIMS Jodhpur will be trained for 2 days.

India-Sweden Healthcare Innovation Centre has been created to address the healthcare challenges in the country through key pillars – Technology, Protocol & Process and Capability Building. This is built under strategic guidance from the Government of India’s Ministry of Health and Family Welfare, the Indian Council of Medical Research (ICMR), the Government of Sweden’s Ministry of Health and Social Affairs and the Embassy of Sweden in India, and knowledge partners AstraZeneca and NASSCOM.

In a phased manner, this capability programme aims to upskill 5000 nurses across the country in the next year by converting the current modules into e-learning. The program also aims to expand the current curriculum to other non-communicable diseases (NCD) areas including Hypertension, Cardiovascular diseases and Oncology.

“Nurses hold transformative power in tackling any disease. The primary idea behind this initiative is to create a framework that can enhance primary, secondary and tertiary care in India. The program we are launching deeply focuses on enriching our nurses with hands-on knowledge and specific skills required to practice and promote up-to-date patient-centric care”, said Cecilia Oskarsson, Trade Commissioner of Sweden to India

 This program is curated from the rich and diverse resources available within the NCD domain following the National Programme for Prevention & Control of Cancer, Diabetes, Cardiovascular Diseases & Stroke (NPCDCS) guidelines.

“Nurses in our country are an important touchpoint that can be leveraged to spread correct medical information to assess and manage these critical lifestyle diseases. Upskilling nurses can prove to be a boon in ensuring the delivery of affordable, standardised and safe essential health care services. Through this initiative, we continue our commitment to address the growing burden of NCDs by setting up solution-oriented centres of excellence that could focus upon upskilling, impactful solutions and scalable operations,” said Dr. Anil Kukreja, VP Medical Affairs, AstraZeneca India